Arnout, J.

patient heparin group anticoagulation level study patency placebo therapy trial thromboplastin baseline alteplase heparin group artery treatment thromboplastin times artery patency european d-dimer levels baseline value blood administration sample value fibrinogen complication table grade subgroup infarction analysis infusion aspirin thromboplastin time angiography study group d-dimer coagulation center result plasma thmmbolytic therapy treatment allocation suboptimal anticoagulation 144 h 6 days ecsg trial patency rate heparin trial placebo group patients randomized 149 patients ischemia system blood samples fibrinogen levels thrombolytic treatment heparin-treated patients suboptimal 652 patients coagulation system 281 patients fibrin patent subgroups reinfarctinn wpt ~reviewed trealment groups lheparin subgroup fibrinogen levels patent thmmbogenic stimuli placebo 01 heparin thmmbop !astm tnnes patency rates ii parlial thromhoplartin limes study group trial selection cril &ia placeb +tre patients onset ofthrombnlytic treatment timi grades 2 timi grade 2